Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Utah Medical Products (UTMD) Revenue (2016 - 2025)

Utah Medical Products has reported Revenue over the past 16 years, most recently at $9.0 million for Q4 2025.

  • Quarterly results put Revenue at $9.0 million for Q4 2025, down 1.23% from a year ago — trailing twelve months through Dec 2025 was $38.5 million (down 5.83% YoY), and the annual figure for FY2025 was $38.5 million, down 5.83%.
  • Revenue for Q4 2025 was $9.0 million at Utah Medical Products, down from $9.8 million in the prior quarter.
  • Over the last five years, Revenue for UTMD hit a ceiling of $13.6 million in Q4 2022 and a floor of $9.0 million in Q4 2025.
  • Median Revenue over the past 5 years was $12.3 million (2022), compared with a mean of $11.5 million.
  • Biggest five-year swings in Revenue: soared 43.44% in 2021 and later decreased 25.75% in 2024.
  • Utah Medical Products' Revenue stood at $12.9 million in 2021, then increased by 5.12% to $13.6 million in 2022, then decreased by 9.15% to $12.3 million in 2023, then fell by 25.75% to $9.2 million in 2024, then decreased by 1.23% to $9.0 million in 2025.
  • The last three reported values for Revenue were $9.0 million (Q4 2025), $9.8 million (Q3 2025), and $10.0 million (Q2 2025) per Business Quant data.